Campus Alert: Find the latest UMMS campus news and resources at

Search Close Search
Search Close Search
Page Menu

Herman G. Berkman Diabetes Clinical Innovation Fund

Herman G. Berkman, PhD, believed greatly in the mission and care model of the UMass Diabetes Center of Excellence. Through a gracious gift made by the late Dr. Berkman, UMass Memorial Health Care established the Berkman Diabetes Clinical Innovation Fund.

Eligibility Guidelines for Berkman Diabetes Clinical Innovation Fund Proposals

The objective of this fund is to support the development of diabetes clinical care initiatives that would not normally find funding through medical billing operational expenses or research grant funding programs. Proposals requesting between $50,000 and $150,000 will be considered. Special consideration is given to proposals that include:

  • Innovative approaches intended to directly improve the lives of people living with diabetes.
  • Multidisciplinary approaches that foster inter-departmental and/or inter-institutional collaborations.
  • Support for individuals, groups, and communities that are economically or educationally disadvantaged or underrepresented.
  • Specific connection to the UMMHC mission in the fields of education and patient care.

Eligibility Guidelines

Approval Process

Faculty and staff of the UMass Memorial Health Care system and the University of Massachusetts Medical School are invited to apply.

The committee will consider funding proposals assessed to have the greatest likelihood of uniquely achieving the objectives described above. Applicants are to submit a brief description of their proposed project for review. Based on submitted proposals, selected applicants will be asked to submit a full proposal that will enable reviewers to fully evaluate the proposed project. Applicants should be prepared to provide a summary of relevant experience, expertise, capabilities, organizational background, project details, and a comprehensive line-item budget (with justification).

How to Apply

Abstract Application 


Email the completed abstract application with a copy of your curriculum vitae to:

Questions? Email: or call Lisa Hubacz, Administrator at (774) 445-3654. 

E-mail submissions only.  No hard copies will be accepted.


Abstract applications will be accepted until 5:00pm on February 1, 2021

2019 Grant Recipient

Leslie J. Domalik, MD, and Asem Ali, MD, were awarded the second annual Herman G. Berkman Diabetes Clinical Innovation Fund grant. Their project is intended to improve blood glucose control for all patients admitted to UMass Memorial hospitals who are living with diabetes. 

Funded Project Summary
The project was developed on the premise that adopting a flexible meal dosing option based on carbohydrate counting will improve the outcomes of hospitalized patients. The study will focus on coordinating appropriate timing of blood glucose testing, insulin dosing, and when rapid acting mealtime insulin is administered. It will also provide carbohydrate counts for all food within the hospitals and better coordinate insulin delivery with when meals are delivered to patients.

2018 Inaugural Grant Recipient

Daniel J. Amante PhD, MPH, and Adarsha S. Bajracharya, MD, were the first recipients of The Herman G. Berkman Diabetes Clinical Innovation Fund. It led to Dr. Amante receiving a three-year KL2 Mentored Career Development Training grant to develop a Diabetes Mellitus program using Behavioral economics to Optimize Outreach and Self-management support with Technology (DM-BOOST). 

Funded Project Summary
ID PLUS Care is a multidisciplinary, collaborative approach to improve care access, quality, and management for at-risk patients with diabetes. The program monitors Electronic Health Record data to identify UMass Medicare Accountable Care Organization patients at risk for negative outcomes and proactively contacts patients to nudge them towards recommended services.